Venture
Eikon Therapeutics, Inc.
Latest Form D 2025-02-28- CIK 1861123
- State CA
- Biotechnology
- 4 Form D offerings since 2021-05-13
- Total sold
- $1.1B
- across 4 offerings
- Rounds
- 4
- Form D offerings since 2021-05-13
- Latest round
- $351M
- 2025-02-28 · 021-539574
- Investors
- 27
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2025-02-28 · $351M
- 2021-05-13$103M021-399311
- 2022-01-06$518M021-428246
- 2023-06-01$141M021-483121
- 2025-02-28$351M021-539574
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($518M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-539574 | First filed2025-02-28 | Latest2025-02-28 | Sought$400M | Sold$351M | Investors27 | Exemptions506(b) |
| 021-483121 | First filed2023-06-01 | Latest2023-06-01 | Sought$535M | Sold$141M | Investors21 | Exemptions506(b) |
| 021-428246 | First filed2022-01-06 | Latest2022-01-06 | Sought$525M | Sold$518M | Investors43 | Exemptions506(b) |
| 021-399311 | First filed2021-05-13 | Latest2021-05-13 | Sought$108M | Sold$103M | Investors12 | Exemptions506(b) |
Who backs Eikon Therapeutics, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-02-28
| Name | Relationship |
|---|---|
| Roger M. Perlmutter | RelationshipExecutive Officer, Director |
| Dror Berman | RelationshipDirector |
| Leon Chen | RelationshipDirector |
| Joshua Wolfe | RelationshipDirector |
| James Tananbaum | RelationshipDirector |
| Kenneth Frazier | RelationshipDirector |
| Robin Washington | RelationshipDirector |
| Robbie Huffines | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2021-05-13
- Latest filing
- 2025-02-28
Who backs Eikon Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗